| A Complexity Lens on the COVID-19 Pandemic | International journal of health policy and management |  | | 2021 | 513 | 392 |
|
| Surveillance of resistance to new antibiotics in an era of limited treatment options | Frontiers in medicine | | | 2021 | 256 | 220 |
|
| Governance in the age of complexity: building resilience to COVID-19 and future pandemics | | | | 2021 | 688 | 317 |
|
| A one health framework to estimate the cost of antimicrobial resistance | Antimicrobial resistance and infection control | | | 2020 | 231 | 180 |
|
| Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus | The Journal of Antibiotics | | | 2020 | 222 | 244 |
|
| Encouraging Sustainable Use of Antibiotics: A Commentary on the DRIVE-AB Recommended Innovation Incentives | The Journal of Law, Medicine & Ethics |  | | 2018 | 384 | 0 |
|
| Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry? | Antibiotics | | | 2018 | 398 | 215 |
|
| Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review | Intensive Care Medicine | | | 2018 | 764 | 3 |
|
| Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality | PLoS medicine | | | 2016 | 501 | 332 |
|
| International cooperation to improve access to and sustain effectiveness of antimicrobials | Lancet | | | 2016 | 577 | 2 |
|
